Philippe Gautret
Philippe Gautret
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,✉,
Frank P Mockenhaupt
Frank P Mockenhaupt
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Frank von Sonnenburg
Frank von Sonnenburg
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Camilla Rothe
Camilla Rothe
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Michael Libman
Michael Libman
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Kristina Van De Winkel
Kristina Van De Winkel
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Emmanuel Bottieau
Emmanuel Bottieau
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Martin P Grobusch
Martin P Grobusch
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Davidson H Hamer
Davidson H Hamer
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Douglas H Esposito
Douglas H Esposito
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Philippe Parola
Philippe Parola
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13,
Patricia Schlagenhauf
Patricia Schlagenhauf
1Institut Hospitalo-Universitaire Méditerranée Infection, Marseille, France (P. Gautret, P. Parola);
2Aix Marseille Université, Marseille (P. Gautret, P. Parola);
3Charité–Universitätsmedizin Berlin, Berlin, Germany (F.P. Mockenhaupt);
4University of Munich, Munich, Germany (F. von Sonnenburg);
5University Clinic Hamburg–Eppendorf, Hamburg, Germany (C. Rothe);
6McGill University, Montreal, Quebec, Canada (M. Libman);
7University Hospital, Ghent, Belgium (K. Van De Winkel);
8Institute of Tropical Medicine, Antwerp, Belgium (E. Bottieau);
9University of Amsterdam, Amsterdam, the Netherlands (M.P. Grobusch);
10Boston University School of Public Health, Boston, Massachusetts, USA (D.H. Hamer);
11Boston Medical Center, Boston (D.H. Hamer);
12Centers for Disease Control and Prevention, Atlanta, Georgia, USA (D.H. Esposito);
13University of Zürich Centre for Travel Medicine, Zurich, Switzerland (P. Schlagenhauf)
1,2,3,4,5,6,7,8,9,10,11,12,13;
for the GeoSentinel Surveillance Network1,2,3,4,5,6,7,8,9,10,11,12,13